首页> 外文OA文献 >SC-535, a Novel Oral Multikinase Inhibitor, Showed Potent Antitumor Activity in Human Melanoma Models

【2h】

SC-535, a Novel Oral Multikinase Inhibitor, Showed Potent Antitumor Activity in Human Melanoma Models

机译：sC-535，一种新型口服多激酶抑制剂，在人类黑色素瘤模型中显示出强大的抗肿瘤活性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Xin Chen; Pan Ji; Hui-Wen Yang; Ling-Ling Yang; Shu Zhou; Lei Zhong; Shuang Ma; Xiao-Yu Fu; Chan Zhou; Guo-Bo Li; Ming-Wu Zheng; Yu-Quan Wei; Sheng-Yong Yang;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. SC-535, a Novel Oral Multikinase Inhibitor, Showed Potent Antitumor Activity in Human Melanoma Models [J] . Xin Chen, Pan Ji, Hui-Wen Yang, Cellular Physiology and Biochemistry . 2013,第1期

机译：SC-535，一种新型的口服多激酶抑制剂，在人类黑素瘤模型中显示出强大的抗肿瘤活性
2. SKLB-287, A novel oral multikinase inhibitor of EGFR and VEGFR2, Exhibits potent antitumor activity in LoVo colorectal tumor model [J] . ChenX., LiuY., YangH.-W., Neoplasma: Journal of Experimental and Clinical Oncology . 2014,第5期

机译：SKLB-287是一种新型的EGFR和VEGFR2口服多激酶抑制剂，在LoVo大肠肿瘤模型中显示出强大的抗肿瘤活性
3. SKLB1206, a Novel Orally Available Multikinase Inhibitor Targeting EGFR Activating and T790M Mutants, ErbB2, ErbB4, and VEGFR2, Displays Potent Antitumor Activity Both In Vitro and In Vivo. [J] . Youli Pan, Yong Xu, Shan Feng, Molecular cancer therapeutics . 2012,第4期

机译：SKLB1206是靶向EGFR激活和T790M突变体ErbB2，ErbB4和VEGFR2的新型口服多激酶抑制剂，在体外和体内均显示出强大的抗肿瘤活性。
4. Sorafenib, a Multikinase Inhibitor: Results from Clinical Trials In Melanoma Patients [C] . Axel Hauschild, Katharina C. Kahler, Friederike Egberts International Symposium on Cancer Metastasis and the Lymphovascular system: Basis for Rational Therapy . 2009

机译：索拉非尼，多立糖酶抑制剂：Melanoma患者的临床试验结果
5. Discovery of a small molecule dihydroquinolinone inhibitor with potent antiproliferative and antitumor activity results in catastrophic cell division. [D] . Christadore, Lisa M. 2013

机译：发现具有有效的抗增殖和抗肿瘤活性的小分子二氢喹啉酮抑制剂会导致灾难性的细胞分裂。
6. YL529 a novel orally available multikinase inhibitor potently inhibits angiogenesis and tumour growth in preclinical models [O] . Youzhi Xu, Hongjun Lin, Nana Meng, 2013

机译：YL529一种新型的口服多激酶抑制剂在临床前模型中有效抑制血管生成和肿瘤生长
7. SKLB-287, a novel oral multikinase inhibitor of EGFR and VEGFR2, exhibits potent antitumor activity in LoVo colorectal tumor model [O] . X. CHEN, Y. LIU, H.-W. YANG, 2014

机译：SKLB-287，EGFR和VEGFR2的新型口服多立糖酶抑制剂，在Lovo结直肠肿瘤模型中表现出有效的抗肿瘤活性

SC-535, a Novel Oral Multikinase Inhibitor, Showed Potent Antitumor Activity in Human Melanoma Models

著录项

引文网络

相似文献

相关主题

期刊订阅